Darmiyan BrainSee FDA Approval for Alzheimer's Diagnosis
Uncategorized

Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer’s Dementia

Today marks a turning point in the battle against Alzheimer’s disease as Darmiyan, Inc., a leading company in brain health innovation announces the FDA’s approval of its first-in-class (De Novo) clinical test, BrainSee. This approval marks a pivotal advancement in brain health and opens the door to untapped market potential in brain disease diagnosis and management. […]

Pulmonary Hypertension Interstitial Lung Disease
Hospital Updates

Pulmonary Fibrosis Foundation and Pulmonary Hypertension Association Provide Guidance on Pulmonary Hypertension Related to Interstitial Lung Disease

The Pulmonary Fibrosis Foundation (PFF) and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the screening, diagnosis and treatment of patients living with pulmonary hypertension (PH) related to interstitial lung disease (PH-ILD). The PH-ILD position statement, featuring a version for patients and a version for healthcare providers, reflects input from experts in interstitial lung disease […]

Hospital Updates

Timely Diagnosis And Early Intervention Of Alzheimer’s Is The Need Of The Hour: Doctors

Alzheimer’s disease (AD) is the most common factor behind dementia, a general term for memory loss and other cognitive abilities that tend to interfere with one’s daily routine. It can impact one’s physical, mental, and emotional well-being. Early diagnosis and prompt medical attention can help the patient to improve their quality of life. Millions of […]

Hospital Updates

AstraZeneca partners with Alveofit to scale up the diagnosis and treatment of lung diseases in India.

Under the aegis of its A.Catalyst network, AstraZeneca India announced its partnership with Alveofit, a SaaS-IoT enabled respiratory healthcare platform, to offer IoT enabled handheld spirometers at hospitals across the country. This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD. […]

Digital Health News

Smile Train India and FOGSI Launch Protocol for Diagnosis and Treatment of Cleft Lip and Palate

Smile Train India, India’s largest cleft focused NGO and The Federation of Obstetric and Gynaecological Societies of India (FOGSI), India’s largest association of gynaecologists and obstetricians, launched a medical protocol for identification and treatment of cleft lip and palate to drive early diagnosis and intervention for children with clefts in India. Cleft Lip and Palate is […]

Digital Health News

Crosscope Strikes Partnership with Mindpeak to Improve Cancer Diagnosis with Digital Pathology Image Analysis

Crosscope Inc. a leading provider of AI-enabled digital pathology software and Mindpeak Gmbh, known for building sophisticated AI tools for clinical diagnosis, today announced their partnership to integrate MIndpeak’s image analysis tools into the Crosscope’s Digital Pathology platform. This partnership will enable Crosscope to expand its portfolio of AI applications and deliver end-to-end digital pathology […]

Digital Health News

Crosscope and BALCO Medical Centre Partner for More Effective Cancer Diagnosis via AI-enabled Digital Pathology Platform

Crosscope Inc, a Silicon Valley-based leader of AI-enabled Digital Pathology Software, and BALCO Medical Centre, flagship unit of Vedanta Medical Research Foundation (VMRF), are joining hands for the digital transformation of their pathology department. This collaboration will focus on using an AI-enabled Digital Pathology Platform from Crosscope, thereby, transforming analog histopathology workflow to AI-enabled digital […]

Drug Updates

P&G Health commemorates Iron Deficiency Day with the launch of the ‘First Iron Deficiency Diagnosis and Counselling Guide’ for Pharmacists

P&G Health, the health care division of Procter & Gamble (NYSE:PG), announced the launch of the ‘First Iron Deficiency Diagnosis and Counselling Guide’ for Pharmacists on the occasion of Iron Deficiency Day 2021. It was developed using the ASHP (American Society of Health-System Pharmacists) Guidelines on Pharmacist-Conducted Patient Education and Counseling and IDA-specific management considerations […]

Hospital Updates

Non-Invasive Liquid Biopsy to Help Cancer Diagnosis Gets CE Certification

Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformité Européenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management. TruBlood is a blood-based, non-invasive test for diagnostic evaluation of suspected cases of cancer who have been recommended a biopsy. The CE marking confirms that TruBlood meets […]